SAM
TMCI icon

Silvercrest Asset Management’s Treace Medical Concepts TMCI Stock Holding History

Silvercrest Asset Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-271,981
Closed -$3.57M – 874
2023
Q3 		$3.57M Buy
271,981
+48,224
+22% +$883K 0.03% 413
2023
Q2 		$5.72M Buy
+223,757
New +$5.78M 0.04% 344

Other funds holding TMCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Silvercrest Asset Management's TMCI Position: Q4 2023 in Review

Silvercrest Asset Management sold out of Treace Medical Concepts (TMCI) in Q4 2023, closing a stake of 271,981 shares — an estimated $3.57M sold.

Silvercrest Asset Management first reported a position in TMCI in Q2 2023 and held it in 2 quarters. The position peaked at $5.72M in Q2 2023. 127 funds tracked by Wall St. Rank hold TMCI as of Q4 2023.

  • Silvercrest Asset Management reported no remaining Treace Medical Concepts position as of Q4 2023 after selling out during the quarter.
  • Silvercrest Asset Management sold 271,981 Treace Medical Concepts shares in Q4 2023, an estimated $3.57M.
  • Silvercrest Asset Management first reported a position in Treace Medical Concepts in Q2 2023 and held it in 2 quarters.
  • Silvercrest Asset Management's Treace Medical Concepts position peaked at $5.72M in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2023.

Based on Silvercrest Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.